The mistreatment of major depressive disorder

Canadian Journal of Psychiatry

Volumn 59, Issue 3, 2014, Pages 148-151

  Paris, Joel ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Antidepressants; Depression; Major depression

Indexed keywords

ANTIDEPRESSANT AGENT;

DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROCONVULSIVE THERAPY; HUMAN; MAJOR DEPRESSION; OUTCOME ASSESSMENT; PSYCHOTHERAPY; REVIEW; SOCIAL PSYCHOLOGY; TREATMENT INDICATION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG THERAPY, COMBINATION; HUMANS; INAPPROPRIATE PRESCRIBING; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 84896500401     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371405900306     Document Type: Review

References (42)

1. Hyman S. The diagnosis of mental disorders: the problem of reification. Ann Rev Clin Psychol. 2010;6:155-179.
2. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ. 2002;324:886-891.
3. Horwitz, AV, Wakefield, JC. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder. New York (NY): Oxford University Press; 2007.
4. Mojtabai R. Clinician-identified depression in community settings: concordance with structured-interview diagnoses. Psychother Psychosom. 2013;82:161-169.
5. Mojtabai R, Olfson M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood). 2011;30:1434-1442.
6. Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010;67:26-36.
7. Berrios GE. Melancholia and depression during the 19th century. A conceptual history. Br J Psychiatry. 1988;153:298-304.
8. Parker G. Beyond major depression. Psychol Med. 2005;35:467-474.
9. Parker G. A case for reprising and redefining melancholia. Can J Psychiatry. 2013;58:183-189.
10. Akiskal HS, McKinney WT Jr. Depressive disorders: toward a unified hypothesis. Science. 1973;182:20-29.
11. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): APA; 2013.
12. Klerman GL. The psychiatric patient's right to effective treatment: implications of Osheroff v Chestnut Lodge. Am J Psychiatry. 1990;147:409-418.
13. Kendler KS, Neale M, Kessler RC, et al. A longitudinal twin study of personality and major depression in women. Arch Gen Psychiatry. 1993;50:853-862.
14. Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry. 1999;156:837-841.
15. Valenstein M. Keeping our eyes on STAR D. Am J Psychiatry. 2006;193:1484-1486.
16. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-Analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5:e45.
17. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-Analysis. JAMA. 2010;303:47-53.
18. Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354:1231-1242.
19. Moffitt TE, Caspi A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2009;40:899-909.
20. Patten SB. Major depression prevalence is high, but the syndrome is a poor proxy for community populations' clinical needs. Can J Psychiatry. 2008;53:411-419.
21. Thombs BD, Coyne JC, Cuijpers P, et al. Rethinking recommendations for screening for depression in primary care. CMAJ. 2012;184:413-418.
22. Fava M, Davidson KG. Definition and epidemiology of treatmentresistant depression. Psychiatr Clin North Am. 1996,19:179-189.
23. Paris J. The use and misuse of psychiatric drugs: an evidence-based guide. London (GB): John Wiley; 2010.
24. Posternak MA, Zimmerman M. Is there a delay in the antidepressant effect? A meta-Analysis. J Clin Psychiatry. 2005;66:148-158.
25. Zimmerman M, Thongy T. How often do SSRIs and other newgeneration antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low. J Clin Psychiatry. 2007;68:1271-1276.
26. Raz A, Campbell N, Guindi D, et al. Placebos in clinical practice: a pan-Canadian review of attitudes and patterns of use between academic psychiatrists and non-psychiatrists. Can J Psychiatry. 2011;56:198-208.
27. Moncrieff J, Cohen D. How do psychiatric drugs work? BMJ. 2009;338:b1963.
28. Wakefield JC, First MB. Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5? World Psychiatry. 2012;11:3-10.
29. Wakefield JC, Schmitz MF, First MB, et al. Extending the bereavement exclusion for major depression to other losses. Arch Gen Psychiatry. 2007;64:43-440.
30. Lambert M. Bergin and Garfield's handbook of psychotherapy and behavior change. New York (NY): Wiley; 2013.
31. Paris J. Prescriptions for the mind: a critical view of contemporary psychiatry. New York (NY): Oxford University Press; 2008.
32. American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder. 3rd ed [Internet]. Washington (DC): APA; 2010 [cited 2013 Nov 15]. Available from: http://psychiatryonline.org/content.aspx?bookid=28§ionid=16674833.
33. National Institute for Health and Care Excellence (NICE). Depression: management of depression in primary and secondary care [Internet]. London (GB): NICE; 2009 [cited 2013 Nov 15]. Available from: http://www.nice.org.uk/ nicemedia/pdf/cg90niceguideline.
34. Patten SB, Kennedy SH, Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CA)NMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord. 2009;117:S5-S14.
35. Lam RW, Grigoriadis S, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CA)NMAT) clinical guidelines for the management of major depressive disorder in adults. II: pharmacotherapy. J Affect Disord. 2009;117:S26-S43.
36. Parikh SV, Segal ZV, Patten SB, et al. Canadian Network for Mood and Anxiety Treatments (CA)NMAT) clinical guidelines for the management of major depressive disorder in adults. III: psychotherapy alone or in combination with antidepressant medication. J Affect Disord. 2009;117:S15-S25.
37. Gottesman I, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636-645.
38. Uher R, Rutter M. Basing psychiatric classification on scientific foundation: problems and prospects. Int Rev Psychiatry. 2012;24:591-605.
39. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-Analysis of published studies. Br J Psychiatry. 2006;188:13-20.
40. Lopez-Castroman J, Galfalvy H, Currier D, et al. Personality disorder assessments in acute depressive episodes: stability at follow-up. J Nerv Ment Dis. 2012;200:526-530.
41. Parker G, Fink M, Akiskal H, et al. Whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry. 2010;167:745-767.
42. Wakefield JC, First MB. The importance and limits of harm in identifying mental disorder. Can J Psychiatry. 2013;58:618-621.